Please enable Javascript to use all features and improve your user experience.
EHC 2023
Programme
People
Search
DE
Back
ePoster
P035
Efficacy and safety of fremanezumab in patients with migraine and obesity: post-hoc analysis of the phase 3 HALO-LTS and FOCUS clinical trials
Mario Ortega
West Chester, US
Appointment
Date:
06/12/2023
Time:
20:45
–
20:50
Talk time:
3 Min.
Discussion time:
2 Min.
Location / Stream:
Headache theatre
Poster
Efficacy and safety of fremanezumab in patients with migraine and obesity: post-hoc analysis of the phase 3 HALO-LTS and FOCUS clinical trials
Session
ePoster 02
Topic
New developments in prophylactic medications and acute medications
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy